Al Ozonoff, PhD, is a biostatistician and clinical trial methodologist specializing in study design, statistical modeling, and translational research. He serves as a faculty member at Boston Children’s Hospital and is affiliated with Harvard Medical School, where he supports multidisciplinary research initiatives spanning pediatrics, neurology, psychiatry, and public health.

Dr. Ozonoff’s expertise centers on the design and analysis of clinical trials, longitudinal cohort studies, and complex biomedical datasets. His work emphasizes rigorous statistical methodology to ensure reproducibility, regulatory readiness, and evidence-based decision-making. He has contributed to numerous federally funded studies and collaborates closely with physician–scientists to translate quantitative findings into clinically meaningful outcomes.

With deep experience in data science, trial oversight, and applied biostatistics, Dr. Ozonoff plays a critical role in strengthening the scientific integrity and statistical robustness of innovative therapeutic development programs.